Introducing a Novel Model to Estimate National and Global Measles Disease Burden
Mark A. Miller, MD
Int J Infect Dis 1999; 4:14-20
Objectives: In discussions of expanded measles control, elimination, and possible
eradication, better estimates of disease burden are increasingly important to target
vaccination control measures. Because global surveillance for measles is inadequate, a
model to quantify country-specific estimates of measles disease burden was formulated to
help policy-makers consider control options. Methods: Country-specific demographics,
developmental status, historic vaccine coverage rates, and age-specific vaccine efficacy and
attack rates were used to determine the number of measles cases and deaths for 5-year
periods. Results: The model estimates an annual global incidence of 32 million
measles-susceptible persons (~25% of the global birth cohort), resulting in 28 million cases
and 691 thousand deaths. Eighty-four percent (578,000) of the global deaths occur in the
World Health Organization African and Southeast Asian regions. Twenty countries account
for 82% of deaths attributable to measles. In nine countries, over 2% of the birth-cohort are
estimated to die from measles. Conclusions: This methodology quantifies country- and
age-specific measles disease burden and establishes regional and global disease patterns,
allowing aggregations by income groups and regions, which aids policy formulation. The
data may be continuously updated, based on dynamic changes in vaccine coverage rates and
the incorporation of national vaccination campaigns.
KEYWORDS:
child mortality, global disease burden, measles, models, vaccines
Back to Table of Contents
The International Journal of Infectious Diseases is owned by
the International Society for Infectious Diseases.
The Journal is published quarterly for the ISID by B.C. Decker Inc.
|